Benefits from specialised cancer care

Lancet

Volumn 348, Issue 9023, 1996, Pages 313-318

  Selby, P ^a,d   Gillis, C ^b   Haward, R ^c,d  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b RUCHILL HOSPITAL   (United Kingdom)

^c Northern and Yorkshire Clinical Trials and Research Unit   (United Kingdom)

^d UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER; CANCER CENTER; HEALTH CARE DELIVERY; HUMAN; LYMPHOPROLIFERATIVE DISEASE; OVARY CANCER; PATIENT REFERRAL; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; TRAINING; UNITED KINGDOM;

EID: 0030567829     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)02482-8     Document Type: Review

References (52)

1. Sontag S. Illness as metaphor. London: Penguin Books, 1983.
2. Wheeler S, Selby P. Confronting cancer - cause and prevention. London: Penguin Books, 1993.
3. Expert Advisory Group on Cancer. A policy framework for commissioning cancer services: a report by the Expert Advisory Group on Cancer to the Chief Medical Officers of England and Wales, 1995. Department of Health. London: HM Stationery Office, 1995.
4. Ham C, Hunter DJ, Robinson R. Evidence-based policy making. BMJ. 310:1995;71-72.
5. Stiller CA. Centralised treatment, entry to trials and survival. Br J Cancer 1994; 70: 352-62.
6. Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakulnen T, Esteve J. Survival of cancer patients in Europe: the EUROCARE study. Lyon: IARC Scientific Publications, 1995.
7. Royal College of Radiologists. Medical manpower and workload in clinical oncology. London: Royal College of Radiologists 1991.
8. Association of Cancer Physicians. Review of the pattern of cancer services in England and Wales. London: Association of Cancer Physicians, 1994.
9. Timothy AR, Squire CJ, for the Clinical Audit Sub-committee of the Faculty of Clinical Oncology, Royal College of Radiologists and the Joint Council for Clinical Oncology. Non-surgical management of early breast cancer in the United Kingdom: workload, referral patterns and staging. Clin Oncol 1995; 7: 213-16.
10. Haines A, Jones R. Implementing findings of research. BMJ 1994; 308: 1488-92.
11. Stiller CA Centralisation of treatment and survival rates for cancer. Arch Dis Child. 63:1988;23-30.
12. Stiller CA, Draper GJ. Treatment centre size, entry to trials and survival in acute lymphoblastic leukaemia. Arch Dis Child 1989; 64: 657-61.
13. Aass N, Klepp O, Cavallin-Stahl E, et al. Prognostic factors in unselected patients with non-seminomatous metastatic testicular cancer: a multicenter experience. J Clin Oncol 1991; 9: 818-26.
14. Harding MJ, Paul J, Gillis CR, Kaye SB Management of malignant teratoma: does referral to a specialist unit matter? Lancet. 341:1993;999-1002.
15. Thornhill JA, Walsh A, Conroy RM, Fennelly JJ, Kelly DG, Fitzpatrick JM. Physician dependent prognostic variables in the management of testicular cancer. Br J Urol 1988; 61: 244-49.
16. Norum J, Nordoy T, Wist E. Testicular cancer treated in a minor general oncology department. Eur J Cancer. 31A:1995;361.
17. Gustafson P, Dreinhofer KE, Rydholm A Soft tissue sarcoma should be treated at a tumour centre. Acta Orthop Scand. 85:1994;47-50.
18. Gillis CR, Hole DJ, Still RM, Davis J, Kaye SB. Medical audit, cancer registration, and survival in ovarian cancer. Lancet 1991; 337: 611-12.
19. Junor EJ, Hole DJ, Gillis C R. Management of ovarian cancer: referral to a multidisciplinary team matters. Br J Cancer 1994; 70: 363-70.
20. Kehoe S, Powell J, Wilson S, Woodman C. The influence of the operating surgeon's specialisation on patient survival in ovarian carcinoma. Br J Cancer 1994; 70: 1014-17.
21. Matthews HR, Powell DJ, McConkey CC. Effects of surgical experience of the results of resection for oesophageal carcinoma. Br J Surg 1986; 73: 621-23.
22. Gulliford MC, Barton JR, Bourne HM Selection for oesophagectomy and postoperative outcome in a defined population. Qual Health Care. 2:1993;17-20.
23. Gordon TA, Burleyson GP, Tielsch JM, Cameron JL The effects of regionalization on cost and outcome for one general high-risk surgical procedure. Ann Surg. 221:1995;43-49.
24. Edge SB, Schmieg RE, Rosenlof LK, Wilhelm MC. Pancreatic cancer resection outcome in American University Centres in 1989-1990. Cancer 1993; 71: 3502-09.
25. Karjalainen S, Palva I. Do treatment protocols improve end results? A study of survival of patients with multiple myeloma in Finland. BMJ 1989; 299: 1069-72.
26. Davis S, Dahlberg S, Myers M, Chen A, Steinhorn SC. Hodgkin's disease in the United States: a comparison of patient characteristics and survival in the centralised cancer patient data system and the surveillance, epidemiology and end results program. J Natl Cancer Inst 1987; 78: 471-78.
27. McArdle CS, Hole D. An analysis of outcome following gastric cancer surgery. Gastrointestinal Cancer 1996; 1: 177-82.
28. Sue-Ling HM, et al. Gastric cancer: a curable disease in Britain. BMJ 1993; 307: 591-96.
29. Bonenkamp JJ, Songun I, Hermans J, et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995; 345: 745-48.
30. Davis S, Wright PW, Schulman SF, et al. Participants in prospective randomised clinical trials for resected non-small cell lung cancer have improved survival compared with non-participants in such trials. Cancer 1985; 56: 1710-18.
31. Romano P, Mark D. Patient and hospital characteristics related to inhospital mortality after lung cancer resection. Chest 1992; 101: 1332-37.
32. Greenberg ER, Baron JA, Dain BJ, Freeman DH, Yates JW, Korson R. Cancer staging may have different meanings in academic and community hospitals. J Clin Epidemiol 1991; 44: 505-12.
33. Hand R, Sener S, Imperato J, Chmiel JS, Sylvester JA, Fremgen A. Hospital variables associated with quality of care for breast cancer patients. JAMA 1991; 266: 3429-32.
34. Basnett I, Gill M, Tobias JAS. Variations in breast cancer management between a teaching and a non-teaching district. Eur J Cancer 1992; 28A: 1945-50.
35. Wolfe C, Barton J, Bourne H. Variation in the incidence and management of primary breast cancer in women under 50 years of age. J Epidemiol Commun Health 1993; 46: 400 (abstr).
36. Byrne MJ, Jamrozik K, Parsons RW, et al. Breast cancer in Western Australia in 1989: diagnosis and primary management. Aust NZ J Surg 1989; 63: 624-29.
37. Davies M. Breast reconstruction - whose choice? A study of present surgical practices. Poster presented at the Fourth Nottingham Breast Conference, 1995.
38. Bofetta P, Merletti F, Winkelmann R, Magnani C, Cappa AP, Terracin B. Survival of breast cancer patients from Piedmont, Italy. Cancer Causes Control 1993; 4: 209-15.
39. Sainsbury R, Haward RA, Rider L, Johnson C, Round C. Influence of clinician workload and patterns of treatment on survival from breast cancer. Lancet 1995; 345: 1265-70.
40. Lazovich D, White E, Thomas D, Moe RE. Underutilization of breast conserving surgery and radiation therapy among women with stage I or II breast cancer. JAMA 1991; 266: 3433-38.
41. Karjalainen S. Geographical variation in cancer patient survival in Finland: chance, confounding or effect of treatment? J Epidemiol Community Health 1990; 44: 210-14.
42. Gillis CR, Hole DJ. Survival outcome of care by specialist surgeons in breast cancer: a study of 3786 patients in the west of Scotland. BMJ 1996; 312: 145-48.
43. McArdle CS, Hole D. Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival. BMJ 1991; 302: 1501-05.
44. McArdle CS, Wotherspoon H, Hole DJ, Murray GD. Colorectal cancer: a continuing problem. Gastrointestinal Cancer 1996; 1: 171-76.
45. Hakama M, Karjalainen S, Hakulinen T. Outcome based equity in the treatment of colon cancer patients in Finland. Int J Technol Assess Health Care 1989; 5: 619-30.
46. Mohner M, Slislow W. Untersuchung zum einfluss der regional zentralisation behandlung auf die uberlebenschancen beim rektumkarzinom in der DDR. Zentralbl Chir 1990; 115: 801-12.
47. Launoy G, Le Coutour X, Gignoux M, Pottier D, Dugleux G. Influence of rural environment on diagnosis, treatment and prognosis of colorectal cancer. J Epidemiol Community Health 1992; 46: 365-67.
48. Hermanek P, Wiebelt H, Staimmer D, Riedl S for German Study Group Colorectal Carcinoma. Prognostic factors of rectum carcinoma: experience of the German Multicentre Study (SGCRC). German Study Group Colorectal Carcinoma. Tumori. 81:1995;60-64.
49. Kingston RD, Walsh S, Jeacock J. Colorectal surgeons in district general hospitals produce similar survival outcomes to their teaching hospital colleagues: review of 5 year survivals in Manchester. J R Coll Surg Edin 1992; 37: 235-37.
50. Begg CB, Carbone PP, Elson PJ, Zelen M. Participation of community hospitals in clinical trials: analysis of five years of experience in the Eastern Cooperative Oncology Group. N Engl J Med 1982; 306: 1076-80.
51. Johnson TP, Ford L, Warnecke RB, et al. Effect of a National Cancer Institute Clinical Alert on breast cancer practice patterns. J Clin Oncol 1994; 12: 1783-88.
52. Winstanely JHR, Leinster SJ, Wake PN, Copeland GP. The value of guidelines in a breast screening service. Eur J Oncol 1995; 21: 140-42.